Anish Bhatnagar
Chief Executive Officer en SOLENO THERAPEUTICS, INC. .
Fortuna: 7 M $ al 31/03/2024
Perfil
Anish Bhatnagar is currently the President, Chief Executive & Operating Officer at Soleno Therapeutics, Inc. He previously worked as a Principal at Titan Pharmaceuticals, Inc. from 2000 to 2006.
He also held a position as a Principal at Coulter Corp.
Dr. Bhatnagar completed his undergraduate degree at SMS Medical College & Hospital.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SOLENO THERAPEUTICS INC
0.47% | 01/04/2024 | 152 790 ( 0.47% ) | 7 M $ | 31/03/2024 |
Cargos activos de Anish Bhatnagar
| Empresas | Cargo | Inicio |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Chief Executive Officer | 01/01/2017 |
Antiguos cargos conocidos de Anish Bhatnagar.
| Empresas | Cargo | Fin |
|---|---|---|
| TITAN PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2006 |
| Coulter Corp | Corporate Officer/Principal | - |
Formación de Anish Bhatnagar.
| SMS Medical College & Hospital | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| TITAN PHARMACEUTICALS, INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
| Coulter Corp | Health Technology |
- Bolsa de valores
- Insiders
- Anish Bhatnagar
